Beacon Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14193 NW 119th Ter Ste 10, Alachua, Flor...Phone Number
(386) 462-2204Website
www.beacontx.comRevenue
$16.3 MillionIndustry
About Beacon Therapeutics
Beacon Therapeutics is a clinical-stage biotechnology company focused on restoring and improving vision through ophthalmic gene therapy. They specialize in treating rare and prevalent ocular diseases, including X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy. Their innovative approach involves modifying patients' cells to produce functional proteins that address genetic conditions, aiming for long-lasting benefits. The company is committed to transforming lives by delivering impactful treatments and is actively seeking talented individuals to join their mission.Explore more
Beacon Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Beacon Therapeutics
Compare insights from companies similar to Beacon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
$85M
2020
LG
Lori GettsHead Co-Founder, Process Development & Preclinical Production At Code Biotherapeutics
Beacon Therapeutics Tech Stack
A closer look at the technologies used by Beacon Therapeutics
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Beacon Therapeutics
Sign Up For FreeTo access detailed company insights
Beacon Therapeutics is a clinical-stage biotechnology company focused on restoring and improving vision through ophthalmic gene therapy. They specialize in treating rare and prevalent ocular diseases, including X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy. Their innovative approach involves modifying p... Read More
